Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$1.66B |
| 2 |
ORIG
Ocean Rig UDW Inc. Class A Common Shares
ORIG
|
+$1.55B |
| 3 |
RTX Corp
RTX
|
+$664M |
| 4 |
NXP Semiconductors
NXPI
|
+$606M |
| 5 |
Walt Disney
DIS
|
+$528M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RAI
Reynolds American Inc
RAI
|
+$1.46B |
| 2 |
KKR & Co
KKR
|
+$602M |
| 3 |
Meta Platforms (Facebook)
META
|
+$594M |
| 4 |
Mastercard
MA
|
+$560M |
| 5 |
Visa
V
|
+$502M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 30.15% |
| 2 | Technology | 10.69% |
| 3 | Financials | 10.06% |
| 4 | Healthcare | 8.47% |
| 5 | Industrials | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5526
Live Ventures
LIVE
$23.5M
| $79K | ﹤0.01% |
6,371
-810
| -11% | -$8.7K |
2013 Q4
15 quarters
|
|
5527
Ultralife
ULBI
$102M
| $79K | ﹤0.01% |
11,686
+164
| +1% | +$1.12K |
2013 Q4
15 quarters
|
|
|
SNDE
5528
DELISTED
Sundance Energy Inc. Common Stock
SNDE
| $79K | ﹤0.01% |
1,710
-345
| -17% | -$15.5K |
2016 Q4
3 quarters
|
|
|
NTX
5529
DELISTED
Nuveen Texas Quality Municipal Income Fund
NTX
| $79K | ﹤0.01% |
5,399
-263
| -5% | -$3.81K |
2013 Q4
15 quarters
|
|
5530
Quoin Pharmaceuticals
QNRX
$8.09M
| – | – |
0
| – | – |
2017 Q1
2 quarters
|
|
5531
Summit State Bank
SSBI
$83.1M
| $78K | ﹤0.01% |
6,929
+20
| +0.3% | +$232 |
2013 Q4
15 quarters
|
|
5532
Air T
AIRT
$80.5M
| $77K | ﹤0.01% |
6,477
-4,167
| -39% | -$47.7K |
2013 Q4
15 quarters
|
|
5533
Lake Shore Bancorp
LSBK
$142M
| $77K | ﹤0.01% |
4,775
| – | – |
2014 Q1
14 quarters
|
|
|
VQT
5534
DELISTED
iPath S&P VEQTOR ETN
VQT
| $77K | ﹤0.01% |
514
-8
| -2% | -$1.18K |
2015 Q4
7 quarters
|
|
5535
DELISTED
Welltower Inc.
WELL.PRI
| $77K | ﹤0.01% |
1,200
-37
| -3% | -$2.42K |
2015 Q4
7 quarters
|
|
|
OMNT
5536
DELISTED
Ominto, Inc. Common Stock
OMNT
| $77K | ﹤0.01% |
17,172
+3,044
| +22% | +$17.7K |
2017 Q1
2 quarters
|
|
5537
ProShares Ultra MSCI EAFE
EFO
$25.2M
| $76K | ﹤0.01% |
1,839
| – | – |
2016 Q3
4 quarters
|
|
|
ALJJ
5538
DELISTED
ALJ Regional Holdings Inc
ALJJ
| $76K | ﹤0.01% |
22,001
-1,181
| -5% | -$3.75K |
2016 Q3
4 quarters
|
|
5539
DELISTED
FGL Holdings Ordinary Shares
FG
| $76K | ﹤0.01% |
6,762
-2,582
| -28% | -$28.4K |
2017 Q2
1 quarter
|
|
|
IPOA.U
5540
DELISTED
Social Capital Hedosophia Holdings Corp.
IPOA.U
| $76K | ﹤0.01% |
+7,163
| New | +$75.2K |
2017 Q3
0 quarters
|
|
|
WBKC
5541
DELISTED
Wolverine Bancorp, Inc.
WBKC
| $76K | ﹤0.01% |
1,760
+1,738
| +7,900% | +$70K |
2017 Q2
1 quarter
|
|
5542
Insight Molecular Diagnostics
IMDX
$100M
| $75K | ﹤0.01% |
493
+185
| +60% | +$19.4K |
2016 Q1
6 quarters
|
|
5543
First Trust Exchange-Traded Fund III First Trust Active Factor Emerging Markets ETF
AFEM
$80.5M
| $75K | ﹤0.01% |
+1,116
| New | +$74.1K |
2017 Q3
0 quarters
|
|
|
CSCI
5544
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
| $75K | ﹤0.01% |
364
+19
| +6% | +$3.5K |
2015 Q3
8 quarters
|
|
|
WBIC
5545
DELISTED
WBI BullBear Yield 2000 ETF
WBIC
| $75K | ﹤0.01% |
3,506
+3,480
| +13,385% | +$75.1K |
2017 Q2
1 quarter
|
|
|
NAVB
5546
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
| $75K | ﹤0.01% |
9,058
+226
| +3% | +$1.92K |
2013 Q2
17 quarters
|
|
5547
LiqTech
LIQT
$12.3M
| $74K | ﹤0.01% |
6,250
-875
| -12% | -$10.1K |
2015 Q4
7 quarters
|
|
5548
Rocket Pharmaceuticals
RCKT
$259M
| $74K | ﹤0.01% |
10,375
-8,501
| -45% | -$38.9K |
2015 Q1
10 quarters
|
|
5549
VOC Energy
VOC
$57.6M
| $74K | ﹤0.01% |
19,617
-2,332
| -11% | -$8.9K |
2013 Q2
17 quarters
|
|
|
CCLP
5550
DELISTED
CSI Compressco LP
CCLP
| $73K | ﹤0.01% |
13,685
-33,539
| -71% | -$161K |
2013 Q4
15 quarters
|
|
Similar funds
Morgan Stanley's Q3 2017 Portfolio in Review
As of Q3 2017, Morgan Stanley held 6,889 positions worth $334B, up 0.86% from $331B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Morgan Stanley's Q3 2017 filing shows 195 new, 3,466 increased, 2,508 reduced and 247 closed positions. Its largest new stake was JBG SMITH: 4,306,383 shares worth $147M. The largest sale was Reynolds American Inc, an estimated $1.46B.
By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, down from 31% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q3 2017 buy was JBG SMITH: 4,306,383 shares worth $147M.
- Morgan Stanley added most to iShares MSCI Emerging Markets ETF in Q3 2017, an estimated $1.66B increase.
- Morgan Stanley's biggest Q3 2017 reduction was KKR & Co, cutting an estimated $602M.
- Morgan Stanley fully exited Reynolds American Inc in Q3 2017, selling an estimated $1.46B.
- Morgan Stanley's ten largest holdings make up 12% of its $334B portfolio in Q3 2017.
- Morgan Stanley opened 195 new positions and closed 247 in Q3 2017.
- Morgan Stanley's portfolio value rose 0.86% quarter-over-quarter to $334B.
Based on Morgan Stanley's 13F filing for Q3 2017, filed 14 Nov 2017.